Literature DB >> 14308233

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

W A CASSEL, R E GARRETT.   

Abstract

Entities:  

Keywords:  ADENOCARCINOMA; ANIMALS, LABORATORY; CARCINOMA, EHRLICH TUMOR; CHICK EMBRYO; EXPERIMENTAL LAB STUDY; HELA CELLS; NEOPLASMS, EXPERIMENTAL; NEWCASTLE DISEASE VIRUS; ONCOLYTIC VIRUSES

Mesh：

Substances：

Year:  1965        PMID： 14308233     DOI： 10.1002/1097-0142(196507)18:7<863::aid-cncr2820180714>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  57 in total

Review 1.  Oncolytic viral therapy of malignant glioma.

Authors:  Jacqueline Nuss Parker; David F Bauer; James J Cody; James M Markert
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

2.  p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines.

Authors:  Zsolt Fábián; Christine M Csatary; József Szeberényi; Laszlo K Csatary
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

3.  Tumor immunity after viral oncolysis.

Authors:  W A Cassel; R E Garrett
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

Review 4.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1966-04       Impact factor: 2.401

5.  Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation.

Authors:  Gayathri Vijayakumar; Dmitriy Zamarin
Journal:  Methods Mol Biol       Date:  2020

6.  A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.

Authors:  F M Batliwalla; B A Bateman; D Serrano; D Murray; S Macphail; V C Maino; J C Ansel; P K Gregersen; C A Armstrong
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

7.  Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models.

Authors:  Sara Cuadrado-Castano; Juan Ayllon; Mena Mansour; Janis de la Iglesia-Vicente; Stefan Jordan; Shashank Tripathi; Adolfo García-Sastre; Enrique Villar
Journal:  Mol Cancer Ther       Date:  2015-03-11       Impact factor: 6.261

8.  MTH-68/H oncolytic viral treatment in human high-grade gliomas.

Authors:  L K Csatary; G Gosztonyi; J Szeberenyi; Z Fabian; V Liszka; B Bodey; C M Csatary
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

9.  Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India.

Authors:  U Kumar; S Kumar
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

10.  Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity.

Authors:  V Schirrmacher; R Heicappell
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.